Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients

MDM2 is an important negative regulator of p53 tumor suppressor. In this study, we sought to investigate the preclinical activity of the MDM2 antagonist, Nutlin-3a, in Philadelphia positive (Ph(+)) and negative (Ph(−)) leukemic cell line models, and primary B-acute lymphoblastic leukemia (ALL) patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Trino, Stefania, Iacobucci, Ilaria, Erriquez, Daniela, Laurenzana, Ilaria, De Luca, Luciana, Ferrari, Anna, Luserna Di Rorà, Andrea Ghelli, Papayannidis, Cristina, Derenzini, Enrico, Simonetti, Giorgia, Lonetti, Annalisa, Venturi, Claudia, Cattina, Federica, Ottaviani, Emanuela, Abbenante, Maria Chiara, Russo, Domenico, Perini, Giovanni, Musto, Pellegrino, Martinelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914334/
https://www.ncbi.nlm.nih.gov/pubmed/26887044
http://dx.doi.org/10.18632/oncotarget.7339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914334/
https://www.ncbi.nlm.nih.gov/pubmed/26887044
http://dx.doi.org/10.18632/oncotarget.7339

Ejemplares similares